These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37599175)

  • 1. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
    An ZY; Wu YJ; Hou Y; Mei H; Nong WX; Li WQ; Zhou H; Feng R; Shen JP; Peng J; Zhou H; Liu Y; Song YP; Yang LH; Fang MY; Li JY; Cheng YF; Liu P; Xu YJ; Wang Z; Luo Y; Cai Z; Liu H; Wang JW; Li J; Zhang X; Sun ZM; Zhu XY; Wang X; Fu R; Huang L; Wang SY; Yang TH; Su LP; Ma LM; Chen XQ; Liu DH; Yao HX; Feng J; Zhang HY; Jiang M; Zhou ZP; Wang WS; Shen XL; Baima Y; Li YY; Wang QF; Huang QS; Fu HX; Zhu XL; He Y; Jiang Q; Jiang H; Lu J; Zhao XY; Chang YJ; Wu T; Pan YZ; Qiu L; Gao D; Jin AR; Li W; Gao SJ; Zhang L; Hou M; Huang XJ; Zhang XH;
    Sci Bull (Beijing); 2023 Sep; 68(18):2106-2114. PubMed ID: 37599175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
    Tsuda H; Tsuji T; Tsuji M; Yamasaki H
    Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.
    Huang QS; Zhu XL; Qu QY; Liu X; Zhang GC; Su Y; Chen Q; Liu FQ; Sun XY; Liang MY; Liu Y; Jiang M; Liu H; Feng R; Yao HX; Zhang L; Qian SX; Yang TH; Zhang JY; Shen XL; Yang LH; Hu JD; Huang RW; Jiang ZX; Wang JW; Zhang HY; Xiao Z; Zhan SY; Liu HX; Chang YJ; Jiang Q; Jiang H; Lu J; Xu LP; Zhang XH; Yin CH; Wang JL; Huang XJ; Zhang XH
    Am J Hematol; 2021 May; 96(5):561-570. PubMed ID: 33606900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.
    Zhao P; Hou M; Liu Y; Liu HX; Huang RB; Yao HX; Niu T; Peng J; Jiang M; Han YQ; Hu JD; Zhou H; Zhou ZP; Qiu L; Zhang LS; Wang X; Wang HQ; Feng R; Yang LH; Ma LM; Wang SQ; Kong PY; Wang WS; Sun HP; Sun J; Zhou HB; Zhu TN; Wang LR; Zhang JY; Huang QS; Liu X; Fu HX; Li YY; Wang QF; Jiang Q; Jiang H; Lu J; Zhang XH
    Platelets; 2021 Jul; 32(5):633-641. PubMed ID: 32614630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study between two bleeding grading systems of immune thrombocytopenia purpura.
    Chen Q; Zhang Y; Li Y; Zhang L; Shi W; Tao H; Chen K; He Z; Wang C; Yu L
    Hematology; 2021 Dec; 26(1):769-774. PubMed ID: 34565307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.
    McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
    Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
    J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical variations between three different causes of thrombocytopenia.
    Akin S; Haznedaroglu IC
    Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.
    Neunert C; Noroozi N; Norman G; Buchanan GR; Goy J; Nazi I; Kelton JG; Arnold DM
    J Thromb Haemost; 2015 Mar; 13(3):457-64. PubMed ID: 25495497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.
    Chong S; Zhao P; Huang RB; Zhou H; Zhang JN; Hou M; Liu Y; Yao HX; Niu T; Peng J; Jiang M; Han YQ; Hu JD; Zhou ZP; Qiu L; Zhang LS; Wang X; Wang HQ; Feng R; Yang LH; Ma LM; Wang SQ; Kong PY; Wang WS; Sun HP; Sun J; Zhou HB; Zhu TN; Wang LR; Zhang JY; Huang QS; Fu HX; Wu YJ; Li YY; Wang QF; Jiang Q; Jiang H; Lu J; Huang XJ; Zhang XH
    Blood Adv; 2022 Jul; 6(14):4320-4329. PubMed ID: 35679462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
    Sirotich E; Guyatt G; Gabe C; Ye Z; Beck CE; Breakey V; Cooper N; Cuker A; Charness J; de Wit K; DiRaimo J; Fein SG; Grace RF; Hassan Z; Jamula E; Kang M; Manski CF; O'Connor C; Pai M; Paynter D; Porter SC; Pruitt B; Strachan G; Webert KE; Yan JW; Kelton JG; Bakchoul T; Arnold DM
    J Thromb Haemost; 2021 Aug; 19(8):2082-2088. PubMed ID: 34327824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?
    Boulware R; Refaai MA
    Thromb Res; 2020 Mar; 187():154-158. PubMed ID: 32004875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram.
    Wang M; Liu W; Xu Y; Wang H; Guo X; Ding X; Quan R; Chen H; Zhu S; Fan T; Li Y; Zhang X; Sun Y; Hu X
    Sci Rep; 2020 Sep; 10(1):15337. PubMed ID: 32948823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
    Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
    J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
    Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
    J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine funduscopy in immune thrombocytopenic purpura-is it really necessary?
    Capua T; Cohen N; Anafy A; Greisman D; Levin D; Rimon A
    Eur J Pediatr; 2019 Jun; 178(6):957-960. PubMed ID: 30937605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
    Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
    J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study between two bleeding grading systems of primary immune thrombocytopenia].
    Xiao S; Liu Q; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):394-398. PubMed ID: 28565738
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.
    Zhou F; Xu Y; Zhang Z; Wu X; Jin R
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
    Li S; Molony JT; Cetin K; Wasser JS; Altomare I
    Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.